ID SDC4_HUMAN Reviewed; 198 AA. AC P31431; O00773; Q16833; Q53FN9; DT 01-JUL-1993, integrated into UniProtKB/Swiss-Prot. DT 15-JUL-1998, sequence version 2. DT 25-JAN-2012, entry version 122. DE RecName: Full=Syndecan-4; DE Short=SYND4; DE AltName: Full=Amphiglycan; DE AltName: Full=Ryudocan core protein; DE Flags: Precursor; GN Name=SDC4; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT LEU-12. RC TISSUE=Lung fibroblast; RX MEDLINE=92363936; PubMed=1500433; DOI=10.1083/jcb.118.4.961; RA David G., van der Schueren B., Marynen P., Cassiman J.-J., RA van den Berghe H.; RT "Molecular cloning of amphiglycan, a novel integral membrane heparan RT sulfate proteoglycan expressed by epithelial and fibroblastic cells."; RL J. Cell Biol. 118:961-969(1992). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=93176185; PubMed=7916598; DOI=10.1006/bbrc.1993.1122; RA Kojima T., Inazawa J., Takamatsu J., Rosenberg R.D., Saito H.; RT "Human ryudocan core protein: molecular cloning and characterization RT of the cDNA, and chromosomal localization of the gene."; RL Biochem. Biophys. Res. Commun. 190:814-822(1993). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC TISSUE=Placenta; RX MEDLINE=96390006; PubMed=8797100; RA Takagi A., Kojima T., Tsuzuki S., Katsumi A., Yamazaki T., Sugiura I., RA Hamaguchi M., Saito H.; RT "Structural organization and promoter activity of the human ryudocan RT gene."; RL J. Biochem. 119:979-984(1996). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-12. RC TISSUE=Stomach; RA Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., RA Tanaka A., Yokoyama S.; RL Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX MEDLINE=21638749; PubMed=11780052; DOI=10.1038/414865a; RA Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., RA Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., RA Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., RA Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., RA Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P., RA Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M., RA Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R., RA Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M., RA Ellington A.G., Frankland J.A., Fraser A., French L., Garner P., RA Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E., RA Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J., RA Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D., RA Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S., RA Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D., RA Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A., RA Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T., RA Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I., RA Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., RA Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., RA Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E., RA Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., RA Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M., RA Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A., RA Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., RA Rogers J.; RT "The DNA sequence and comparative analysis of human chromosome 20."; RL Nature 414:865-871(2001). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Lung; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP SHEDDING. RX PubMed=9169435; DOI=10.1074/jbc.272.23.14713; RA Subramanian S.V., Fitzgerald M.L., Bernfield M.; RT "Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and RT growth factor receptor activation."; RL J. Biol. Chem. 272:14713-14720(1997). RN [8] RP INTERACTION WITH CDCP1. RX PubMed=16007225; DOI=10.1038/sj.onc.1208582; RA Bhatt A.S., Erdjument-Bromage H., Tempst P., Craik C.S., Moasser M.M.; RT "Adhesion signaling by a novel mitotic substrate of src kinases."; RL Oncogene 24:5333-5343(2005). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-197, AND MASS RP SPECTROMETRY. RC TISSUE=Lung carcinoma; RX PubMed=18083107; DOI=10.1016/j.cell.2007.11.025; RA Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., RA Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., RA Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J., RA Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., RA Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; RT "Global survey of phosphotyrosine signaling identifies oncogenic RT kinases in lung cancer."; RL Cell 131:1190-1203(2007). RN [10] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-197, AND MASS RP SPECTROMETRY. RC TISSUE=Mammary epithelium; RX PubMed=17389395; DOI=10.1073/pnas.0608638104; RA Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; RT "Multiple reaction monitoring for robust quantitative proteomic RT analysis of cellular signaling networks."; RL Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). RN [11] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-197, AND MASS RP SPECTROMETRY. RC TISSUE=Mammary epithelium; RX PubMed=19534553; DOI=10.1021/pr900044c; RA Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A., RA Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D., RA Wiley H.S., Qian W.-J.; RT "An extensive survey of tyrosine phosphorylation revealing new sites RT in human mammary epithelial cells."; RL J. Proteome Res. 8:3852-3861(2009). RN [12] RP STRUCTURE BY NMR OF 171-198. RX MEDLINE=21349687; PubMed=11456484; DOI=10.1021/bi002750r; RA Shin J., Lee W., Lee D., Koo B.-K., Han I., Lim Y., Woods A., RA Couchman J.R., Oh E.-S.; RT "Solution structure of the dimeric cytoplasmic domain of syndecan-4."; RL Biochemistry 40:8471-8478(2001). RN [13] RP X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 193-198 IN COMPLEX WITH RP SDCBP. RX PubMed=12842047; DOI=10.1016/S0969-2126(03)00125-4; RA Kang B.S., Cooper D.R., Devedjiev Y., Derewenda U., Derewenda Z.S.; RT "Molecular roots of degenerate specificity in syntenin's PDZ2 domain: RT reassessment of the PDZ recognition paradigm."; RL Structure 11:845-853(2003). RN [14] RP X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 182-198 IN COMPLEX WITH RP SDCBP. RX PubMed=16533050; DOI=10.1021/bi052225y; RA Grembecka J., Cierpicki T., Devedjiev Y., Derewenda U., Kang B.S., RA Bushweller J.H., Derewenda Z.S.; RT "The binding of the PDZ tandem of syntenin to target proteins."; RL Biochemistry 45:3674-3683(2006). CC -!- FUNCTION: Cell surface proteoglycan that bears heparan sulfate. CC -!- SUBUNIT: Homodimer. Interacts (via its cytoplasmic domain) with CC GIPC (via its PDZ domain). Interacts (via its cytoplasmic domain) CC with NUDT16L1 (By similarity). Interacts with CDCP1 and SDCBP. CC -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane CC protein. Secreted. Note=Shedding of the ectodomain produces a CC soluble form (By similarity). CC -!- TISSUE SPECIFICITY: Expressed in epithelial and fibroblastic CC cells. CC -!- PTM: Shedding is enhanced by a number of factors such as CC heparanase, thrombin or EGF. Also by stress and wound healing. CC PMA-mediated shedding is inhibited by TIMP3. CC -!- SIMILARITY: Belongs to the syndecan proteoglycan family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; X67016; CAA47406.1; -; mRNA. DR EMBL; D13292; BAA02550.1; -; mRNA. DR EMBL; D79206; BAA19613.1; -; Genomic_DNA. DR EMBL; AK222695; BAD96415.1; -; mRNA. DR EMBL; AK223243; BAD96963.1; -; mRNA. DR EMBL; AL021578; CAA16520.1; -; Genomic_DNA. DR EMBL; BC030805; AAH30805.1; -; mRNA. DR IPI; IPI00011564; -. DR PIR; JC1457; JC1457. DR RefSeq; NP_002990.2; NM_002999.3. DR UniGene; Hs.632267; -. DR PDB; 1EJP; NMR; -; A/B=171-198. DR PDB; 1EJQ; NMR; -; A/B=171-198. DR PDB; 1OBY; X-ray; 1.85 A; P/Q=193-198. DR PDB; 1YBO; X-ray; 2.30 A; C/D=182-198. DR PDBsum; 1EJP; -. DR PDBsum; 1EJQ; -. DR PDBsum; 1OBY; -. DR PDBsum; 1YBO; -. DR ProteinModelPortal; P31431; -. DR SMR; P31431; 171-198. DR DIP; DIP-29945N; -. DR IntAct; P31431; 2. DR MINT; MINT-140673; -. DR STRING; P31431; -. DR TCDB; 9.A.35.1.1; peptide translocating syndecan family. DR PhosphoSite; P31431; -. DR DMDM; 2851418; -. DR PRIDE; P31431; -. DR Ensembl; ENST00000372733; ENSP00000361818; ENSG00000124145. DR GeneID; 6385; -. DR KEGG; hsa:6385; -. DR UCSC; uc002xnu.1; human. DR CTD; 6385; -. DR GeneCards; GC20M043953; -. DR H-InvDB; HIX0015856; -. DR HGNC; HGNC:10661; SDC4. DR HPA; CAB013240; -. DR HPA; HPA005716; -. DR MIM; 600017; gene. DR neXtProt; NX_P31431; -. DR PharmGKB; PA35591; -. DR eggNOG; prNOG05282; -. DR HOGENOM; HBG278903; -. DR HOVERGEN; HBG004501; -. DR InParanoid; P31431; -. DR OMA; NHIPERA; -. DR OrthoDB; EOG4MSD0Z; -. DR PhylomeDB; P31431; -. DR Pathway_Interaction_DB; syndecan_pathway; Proteogylcan syndecan-mediated signaling events. DR Pathway_Interaction_DB; syndecan_4_pathway; Syndecan-4-mediated signaling events. DR NextBio; 24792; -. DR PMAP-CutDB; P31431; -. DR ArrayExpress; P31431; -. DR Bgee; P31431; -. DR CleanEx; HS_SDC4; -. DR Genevestigator; P31431; -. DR GermOnline; ENSG00000124145; Homo sapiens. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB. DR GO; GO:0008092; F:cytoskeletal protein binding; IEA:InterPro. DR GO; GO:0070053; F:thrombospondin receptor activity; IMP:BHF-UCL. DR InterPro; IPR003585; Neurexin-like. DR InterPro; IPR001050; Syndecan. DR KO; K06257; -. DR PANTHER; PTHR10915; Syndecan; 1. DR Pfam; PF01034; Syndecan; 1. DR SMART; SM00294; 4.1m; 1. DR PROSITE; PS00964; SYNDECAN; 1. PE 1: Evidence at protein level; KW 3D-structure; Complete proteome; Glycoprotein; Heparan sulfate; KW Membrane; Phosphoprotein; Polymorphism; Proteoglycan; KW Reference proteome; Secreted; Signal; Transmembrane; KW Transmembrane helix. FT SIGNAL 1 18 Potential. FT CHAIN 19 198 Syndecan-4. FT /FTId=PRO_0000033511. FT TOPO_DOM 19 145 Extracellular (Potential). FT TRANSMEM 146 170 Helical; (Potential). FT TOPO_DOM 171 198 Cytoplasmic (Potential). FT MOD_RES 197 197 Phosphotyrosine. FT CARBOHYD 39 39 O-linked (Xyl...) (heparan sulfate) (By FT similarity). FT CARBOHYD 61 61 O-linked (Xyl...) (heparan sulfate) FT (Potential). FT CARBOHYD 63 63 O-linked (Xyl...) (heparan sulfate) FT (Potential). FT VARIANT 12 12 F -> L (in dbSNP:rs4458268). FT /FTId=VAR_021851. FT STRAND 196 198 SQ SEQUENCE 198 AA; 21642 MW; 8229AA2733F77A10 CRC64; MAPARLFALL LFFVGGVAES IRETEVIDPQ DLLEGRYFSG ALPDDEDVVG PGQESDDFEL SGSGDLDDLE DSMIGPEVVH PLVPLDNHIP ERAGSGSQVP TEPKKLEENE VIPKRISPVE ESEDVSNKVS MSSTVQGSNI FERTEVLAAL IVGGIVGILF AVFLILLLMY RMKKKDEGSY DLGKKPIYKK APTNEFYA //